Induction of CEA-specific Cytotoxic T Lymphocytes by Murine Dendritic Cells Expressing CEA

EH Won, CH Kim, MY Park, HI Cho, ST Oh… - Immune …, 2003 - koreascience.kr
Background: Carcinoembryonic antigen (CEA) is well-known soluble tumor marker
frequently detectable in peripheral blood of carcinoma patients and considered as good …

[PDF][PDF] CEA 발현수지상세포를이용한CEA 특이살해T 세포의유도

원은하, 김창현, 박미영, 조현일, 오승택… - Immune …, 2003 - immunenetwork.org
Background: Carcinoembryonic antigen (CEA) is well-known soluble tumor marker
frequently detectable in peripheral blood of carcinoma patients and considered as good …

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA

E Eppler, H Hörig, HL Kaufman, P Groscurth… - European Journal of …, 2002 - Elsevier
The feasibility of dendritic cells (DC) for cancer immunotherapy after transfection by
electroporation with mRNA encoding the human carcinoembryonic antigen (CEA) was …

Induction of carcinoembryonic antigen (cea)‐specific cytotoxic t‐lymphocyte responses In vitro using autologous dendritic cells loaded with cea peptide or cea rna in …

SK Nair, S Hull, D Coleman, E Gilboa… - … journal of cancer, 1999 - Wiley Online Library
The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies
on the generation of potent DC capable of presenting tumor antigens such as …

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses

HI Cho, HJ Kim, ST Oh, TG Kim - Vaccine, 2003 - Elsevier
Carcinoembryonic antigen (CEA), which is expressed in several cancer types, is a potential
target for specific immunotherapy. In this study, the feasibility of using dendrite cells (DCs) …

Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli

MY Bae, NH Cho, SY Seong - Clinical & Experimental …, 2009 - academic.oup.com
Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has
been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific …

Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire

SE Alters, JR Gadea, M Sorich… - Journal of …, 1998 - journals.lww.com
The human carcinoembryonic antigen (CEA), which is expressed in several cancer types is
a potential target for antigen-specific immunotherapy. In this study, we show that dendritic …

In vitro induction of carcinoembryonic antigen (CEA) specific cytotoxic T lymphocytes using dendritic cells pulsed with CEA peptide

MH PARK, CS LEE, MH CHO, C Han… - Journal of the …, 2005 - pesquisa.bvsalud.org
PURPOSE: Dendritic cells (DCs) are the most potent antigen-presenting cells for initiating
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …

Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide

ST Oh, CH Kim, MY Park, EH Won, HJ Sohn, HI Cho… - Vaccine, 2006 - Elsevier
Transduction with recombinant, replication-defective adenovirus (AdV) vectors encoding a
transgene is an efficient method for gene transfer into murine or human dendritic cells (DC) …

Immunotherapy of cancer: generation of CEA specific CTL using CEA peptide pulsed dendritic cells

SE Alters, JR Gadea, R Philip - Dendritic Cells in Fundamental and …, 1997 - Springer
Antigen specific cytotoxic T lymphocytes (CTL) are being studied for their potential
immunotherapeutic benefit in the treatment of cancer. Carcinoembryonic antigen (CEA) is an …